Literature DB >> 21989346

Oncocytic adrenocortical tumors: diagnostic algorithm and mitochondrial DNA profile in 27 cases.

Eleonora Duregon1, Marco Volante, Susanna Cappia, Alessandra Cuccurullo, Michele Bisceglia, Daniel D Wong, Dominic V Spagnolo, Sylwia Szpak-Ulczok, Enrico Bollito, Fulvia Daffara, Alfredo Berruti, Massimo Terzolo, Mauro Papotti.   

Abstract

The pathologic diagnosis of adrenocortical carcinoma (ACC) relies on microscopic features that are sometimes equivocal in special variants, including oncocytic adrenocortical tumors (OACTs). We report a series of 27 unpublished OACTs (15 pure and 12 mixed or focal) and assess for the first time in OACTs the diagnostic utility of an algorithm recently proposed by our group ("reticulin" algorithm) for conventional ACCs on the basis of a combination of reticulin staining and assessment of only 3 Weiss parameters. Overall, 12 cases were malignant according to the Lin-Weiss-Bisceglia (L-W-B) system for pure tumors and the original Weiss system for mixed or focal tumors; extensive or focal disruption of the reticulin network was found in 16 of 27 OACTs. This was associated with either a high mitotic index, presence of necrosis, and/or vascular invasion in 14 of these, which were thus considered malignant according to our algorithm. From a clinical standpoint, OACTs, at least in the pure form, are "low grade" lesions with a low mean Weiss score, mitotic and Ki-67 indices, and uncommon capsular or vascular invasion. They, including unequivocal morphologically malignant cases, generally pursue an indolent clinical course. In addition, the 4977 bp mitochondrial DNA "common deletion" was detected using real-time polymerase chain reaction in 54% of cases from this study and an additional validation series of 23 OACTs, with a heterogenous (heteroplasmic) intratissue and intracellular distribution (as detected by a modified FISH procedure) and a marked association with the presence of intact reticulin framework.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21989346     DOI: 10.1097/PAS.0b013e31822da401

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  10 in total

1.  Bilateral adrenocortical oncocytoma with bilateral myelolipomatous metaplasia.

Authors:  Charu Shastri; Chanchal Rana; Niraj Kumari; Gaurav Agarwal; Narendra Krishnani
Journal:  Endocr Pathol       Date:  2012-06       Impact factor: 3.943

2.  Pathology of the adrenal cortex: a reappraisal of the past 25 years focusing on adrenal cortical tumors.

Authors:  Mauro Papotti; Eleonora Duregon; Marco Volante; Anne Marie McNicol
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

3.  Association between mitochondrial and nuclear DNA damages and cellular senescence in the patients with biliary atresia undergoing Kasai portoenterostomy and liver transplantation.

Authors:  Yudai Nakajima; Yuto Yamazaki; Xin Gao; Masatoshi Hashimoto; Masaki Nio; Motoshi Wada; Fumiyoshi Fujishima; Hironobu Sasano
Journal:  Med Mol Morphol       Date:  2022-03-03       Impact factor: 2.309

4.  Case report: adrenal oncocytoma associated with markedly increased FDG uptake and immunohistochemically positive for GLUT1.

Authors:  Naomi Sato; Yasuhiro Nakamura; Kentaro Takanami; Yoshikiyo Ono; Kei Omata; Ryo Morimoto; Fumitoshi Satoh; Kazue Ise; Shigeyuki Yamada; Atsuko Kasajima; Fumiyoshi Fujishima; Mika Watanabe; Yoichi Arai; Hironobu Sasano
Journal:  Endocr Pathol       Date:  2014-12       Impact factor: 3.943

5.  Adrenocortical oncocytoma presenting as Cushing's syndrome: an additional report of a paediatric case.

Authors:  Bernardo Dias Pereira; Elisabete Silva Rios; Rafael Adame Cabrera; Jorge Portugal; Luísa Raimundo
Journal:  Endocr Pathol       Date:  2014-12       Impact factor: 3.943

6.  Transcriptome in paraffin samples for the diagnosis and prognosis of adrenocortical carcinoma.

Authors:  Anne Jouinot; Juliane Lippert; Mathilde Sibony; Florian Violon; Lindsay Jeanpierre; Daniel De Murat; Roberta Armignacco; Amandine Septier; Karine Perlemoine; Franck Letourneur; Brigitte Izac; Bruno Ragazzon; Karen Leroy; Eric Pasmant; Marie-Odile North; Sébastien Gaujoux; Bertrand Dousset; Lionel Groussin; Rossella Libe; Benoit Terris; Martin Fassnacht; Cristina L Ronchi; Jérôme Bertherat; Guillaume Assie
Journal:  Eur J Endocrinol       Date:  2022-04-21       Impact factor: 6.558

7.  Steroidogenic enzyme profile in an androgen-secreting adrenocortical oncocytoma associated with hirsustism.

Authors:  Milène Tetsi Nomigni; Sophie Ouzounian; Alice Benoit; Jacqueline Vadrot; Frédérique Tissier; Sylvie Renouf; Hervé Lefebvre; Sophie Christin-Maitre; Estelle Louiset
Journal:  Endocr Connect       Date:  2015-06-01       Impact factor: 3.335

8.  Functional plurihormonal adrenal oncocytoma: case report and literature review.

Authors:  Pablo René Costanzo; Andrea Laura Paissan; Pablo Knoblovits
Journal:  Clin Case Rep       Date:  2017-11-22

Review 9.  Laparoscopic Trans-Abdominal Right Adrenalectomy for a Large Primitive Adrenal Oncocytic Carcinoma: A Case Report and Review of Literature.

Authors:  Valerio Panizzo; Barbara Rubino; Guglielmo Niccolò Piozzi; Paolo Ubiali; Anna Morandi; Marco Nencioni; Giancarlo Micheletto
Journal:  Am J Case Rep       Date:  2018-09-15

10.  Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors.

Authors:  Gerald Goh; Ute I Scholl; James M Healy; Murim Choi; Manju L Prasad; Carol Nelson-Williams; John W Kunstman; John W Kuntsman; Reju Korah; Anna-Carinna Suttorp; Dimo Dietrich; Matthias Haase; Holger S Willenberg; Peter Stålberg; Per Hellman; Göran Akerström; Peyman Björklund; Tobias Carling; Richard P Lifton
Journal:  Nat Genet       Date:  2014-04-20       Impact factor: 38.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.